Education
About Us
Working with TipRanks
Follow Us
SeaStar Medical Holding (ICU)
NASDAQ:ICU
Earnings Data
Report Date
Mar 26, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.11Last Year’s EPS
-0.9Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call showcased several positive developments, including impressive survival results from Quellimmune therapy, significant revenue growth, and a high gross profit margin. The expansion of clinical sites and a strengthened financial position further underline the company's potential. However, the variability in sales and the increased enrollment requirement for the pivotal trial pose challenges. Despite these, the overall sentiment is positive with a strategic focus on overcoming hurdles and continuing growth.Company Guidance
Impressive Survival Results for Quellimmune
Reported very impressive survival results for the use of Quellimmune therapy in 21 pediatric patients, with 76% surviving through 60 days and 71% through 90 days.
Revenue Growth and Projections
Net revenue for Quellimmune in the third quarter was $183,000, a 45% increase compared to the first six months of the year. Full-year revenue for 2025 is projected to exceed $1 million.
High Gross Profit Margin
Achieved a gross profit margin of 92%, similar to a branded pharmaceutical product.
Expansion of Clinical Sites
Onboarded three additional clinical sites for the neutralized AKI trial, bringing the total to 17 active sites, with plans to activate eight more.
Financial Strengthening
Raised over $12 million to strengthen the balance sheet and extend the financial runway.
ICU Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ICU Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $0.46 | $0.38 | -17.39% |
Aug 13, 2025 | $0.73 | $0.88 | +20.55% |
May 14, 2025 | $1.23 | $1.24 | +0.81% |
Mar 27, 2025 | $2.20 | $1.70 | -22.73% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does SeaStar Medical Holding (ICU) report earnings?
SeaStar Medical Holding (ICU) is schdueled to report earning on Mar 26, 2026, After Close (Confirmed).
What is SeaStar Medical Holding (ICU) earnings time?
SeaStar Medical Holding (ICU) earnings time is at Mar 26, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ICU EPS forecast?
ICU EPS forecast for the fiscal quarter 2025 (Q4) is -0.11.